Underlying IPEX syndrome in a patient with idiopathic juvenile arthritis and vitiligo

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMENDONCA, Leonardo Oliveira
dc.contributor.authorCHUSTER, Adriana Pitchon dos Reis
dc.contributor.authorDORNA, Mayra Barros
dc.contributor.authorBARROS, Samar Freschi
dc.contributor.authorALVES, Janaina Baptista
dc.contributor.authorGONCALVES, Victor Lucas
dc.contributor.authorYANG, Ariana Campos
dc.contributor.authorKALIL, Jorge
dc.contributor.authorTOLEDO-BARROS, Myrthes Anna Maragna
dc.contributor.authorKOKRON, Cristina Maria
dc.date.accessioned2023-02-23T14:52:18Z
dc.date.available2023-02-23T14:52:18Z
dc.date.issued2022
dc.description.abstractBackground: IPEX syndrome is an X-linked inborn error of immunity clinically characterized by the triad of: enteropathy, polyendocrinopathy and eczema. However many other clinical presentations lacking the triad above described have been reported what underpin the need of careful clinical suspicion, immunological evaluation and genetic sequencing. Case presentation: Here we report a case of a Brazilian boy with severe eczema as the first and only presentation requiring cyclosporin therapy. Progressive and cumulative symptoms of arthritis and enteropathy lead to the suspicion of an inborn error of immunity. Peripheral FOXP3 expression was normal (CD127-/CD4+/CD25+/FOXP3+-396 cells-63%) and a pathogenic mutation in FOXP3 gene (c.1150G > A; p.Ala384Thr), confirmed the diagnosis of IPEX syndrome. Conclusions: IPEX syndrome should be suspected in patients presenting with severe eczema associated or not with other autoimmune/hyper inflammatory diseases in life. Our study also reinforces that FOXP3 expression by flowcytometry seems not to be a good screening method, and genetic sequencing is mandatory even in those with high suspicion and normal peripheral FOXP3 expression.eng
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.identifier.citationALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, v.18, n.1, article ID 105, 6p, 2022
dc.identifier.doi10.1186/s13223-022-00740-9
dc.identifier.issn1710-1492
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/51394
dc.language.isoeng
dc.publisherBMCeng
dc.relation.ispartofAllergy Asthma and Clinical Immunology
dc.rightsopenAccesseng
dc.rights.holderCopyright BMCeng
dc.subject.wosAllergyeng
dc.subject.wosImmunologyeng
dc.titleUnderlying IPEX syndrome in a patient with idiopathic juvenile arthritis and vitiligoeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcLEONARDO OLIVEIRA MENDONCA
hcfmusp.contributor.author-fmusphcADRIANA PITCHON DOS REIS CHUSTER
hcfmusp.contributor.author-fmusphcMAYRA DE BARROS DORNA
hcfmusp.contributor.author-fmusphcSAMAR FRESCHI DE BARROS
hcfmusp.contributor.author-fmusphcJANAINA BAPTISTA ALVES
hcfmusp.contributor.author-fmusphcVICTOR LUCAS GONCALVES
hcfmusp.contributor.author-fmusphcARIANA CAMPOS YANG
hcfmusp.contributor.author-fmusphcJORGE ELIAS KALIL FILHO
hcfmusp.contributor.author-fmusphcMYRTHES ANNA MARAGNA TOLEDO BARROS
hcfmusp.contributor.author-fmusphcCRISTINA MARIA KOKRON
hcfmusp.description.articlenumber105
hcfmusp.description.issue1
hcfmusp.description.volume18
hcfmusp.origemWOS
hcfmusp.origem.pubmed36503523
hcfmusp.origem.scopus2-s2.0-85143655694
hcfmusp.origem.wosWOS:000897780700001
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAl Maawali A, 2020, CASE REP IMMUNOL, V2020, DOI 10.1155/2020/9860863eng
hcfmusp.relation.referenceBacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011eng
hcfmusp.relation.referenceBachelerie M, 2019, ANN DERMATOL VENER, V146, P807, DOI 10.1016/j.annder.2019.04.026eng
hcfmusp.relation.referenceBarzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041eng
hcfmusp.relation.referenceBennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713eng
hcfmusp.relation.referenceCARNEIROSAMPAIO MMS, 1989, ALLERGOL IMMUNOPATH, V17, P213eng
hcfmusp.relation.referenceCastagnoli R, 2021, WORLD ALLERGY ORGAN, V14, DOI 10.1016/j.waojou.2021.100513eng
hcfmusp.relation.referenceGambineri E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02411eng
hcfmusp.relation.referenceGe T, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00267eng
hcfmusp.relation.referenceGentile M, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.854749eng
hcfmusp.relation.referenceJahan P, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00249eng
hcfmusp.relation.referenceKanegane H, 2018, ALLERGOL INT, V67, P43, DOI 10.1016/j.alit.2017.06.003eng
hcfmusp.relation.referencePark JH, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102526eng
hcfmusp.relation.referenceToyama D, 2021, J CLIN IMMUNOL, V41, P1683, DOI 10.1007/s10875-021-01092-6eng
hcfmusp.relation.referenceZama D, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0068-4eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication1cc5ca7b-b9b5-4c21-a104-f980e6fb2077
relation.isAuthorOfPublicationa6d74404-24bd-4555-bfab-f0f99e7db8aa
relation.isAuthorOfPublicationd4166723-dc5c-4b7e-ad2f-ef6508471afb
relation.isAuthorOfPublication5e4d44d0-1ab2-4a50-abfc-9fea9ba7a4fd
relation.isAuthorOfPublication1e708e27-82ed-4f5d-841a-84710cad5016
relation.isAuthorOfPublication2b6e5c9c-64bd-44a5-aaff-08b3913ff4b0
relation.isAuthorOfPublicationca629b81-6c24-41d3-a66d-99d3aa93441e
relation.isAuthorOfPublication039713b4-cdee-430a-b5dd-77d7d751b09b
relation.isAuthorOfPublication94293f42-569b-4d52-bf8d-473009a3a4fd
relation.isAuthorOfPublication1ecdd4f2-6e9c-45af-b110-761e6bfdec3c
relation.isAuthorOfPublication.latestForDiscovery1cc5ca7b-b9b5-4c21-a104-f980e6fb2077
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_MENDONCA_Underlying_IPEX_syndrome_in_a_patient_with_idiopathic_2022.PDF
Tamanho:
921.09 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)